Smith v. Nexus RVs, LLC

District Court, N.D. Indiana·Decided November 19, 2021·No. 3:17-cv-00815·Unknown

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF INDIANA SOUTH BEND DIVISION

LINDA AND KEN SMITH,

Plaintiffs,

v. CAUSE NO. 3:17-CV-815 DRL

NEXUS RVS, LLC and ALLY FINANCIAL, INC.,

Defendant.

OPINION & ORDER

The court held a four-day jury trial that concluded May 27, 2021. The jury returned a verdict for Linda and Ken Smith on their Indiana Deceptive Consumer Sales Act (IDCSA) claim and awarded $150,000 in damages. Following trial, the Smiths requested judgment as a matter of law on the sufficiency of the defense’s pre-suit cure letter, treble damages, attorney fees, and costs. Nexus contests each of these requests. The court takes up each issue in turn. DISCUSSION A. Pre-Suit Letter.

The Smiths ask the court to rule as a matter of law that the letter sent by Nexus RVs, LLC (through counsel) wasn’t an “offer to cure” as defined by the IDCSA. See Ind. Code §§ 24-5-0.5- 2(a)(5), (a)(6). Nexus argues that the court cannot consider the pre-suit letter because it wasn’t admitted as an exhibit at trial. One has nothing to do with the other when it comes to attorney fees. A motion for attorney fees isn’t contingent on just trial evidence. “A claim for attorney’s fees and related nontaxable expenses must be made by motion unless the substantive law requires those fees to be proved at trial as an element of damages.” Fed. R. Civ. P. 54(d)(2)(A). Nothing within the IDCSA (the substantive law) requires attorney fees to be proved at trial. The statute speaks in terms of a “proceeding,” not a trial; and nothing removes that common question from the court to require a factfinder to decide the issue instead. See Ind. Code §§ 24-5-0.5- 4(j), (k). In fact, the IDCSA expressly contemplates that the court will decide the question. See Ind. Code § 24-5-0.5-4(a) (“the court may award reasonable attorney fees to the party that prevails”). The court retains the discretion to establish the procedure for deciding attorney fees under Rule 54. That procedure may include reviewing additional information to help the court resolve the fee issue, and even in rare occasions permitting discovery to develop that information. See Wright &

Miller, 10 Fed. Prac. & Proc. Civ. § 2680 (4th ed.); see, e.g., Hogan v. Fairfax Cnty. Sch. Bd., 645 F. Supp.2d 554, 577 (E.D. Va. 2009). For instance, it is customary for the court to consider billings, affidavits, and other information to decide the fee question. The IDCSA leaves the court’s discretion undisturbed. If an offer to cure is timely, a supplier may submit it as evidence to prove that the supplier actually made one. See Ind. Code § 24-5-0.5-4(j); see also Ind. Code §§ 24-5-0.5-2(a)(6), 24-5-0.5-4(a). In addition, the IDCSA also allows the court to consider a timely offer to cure when the supplier wishes to avoid attorney fees—as here. See Ind. Code § 24-5-0.5-4(j)(1), (j)(2). In short, the court may consider the letter. The Smiths attached the letter to their motion [ECF 128-1]. Under the IDCSA, a supplier may not be held liable for fees and costs “following the timely delivery of an offer to cure . . . unless the actual damages awarded, not including attorney’s fees and costs, exceed the value of the offer to cure.” Ind. Code. § 24-5-0.5-4(k). An “offer to cure” is one that “is reasonably calculated to remedy a loss claimed by the consumer” and “includes a minimum additional amount that is the greater of: (i) ten

percent (10%) of the value of the remedy [reasonably calculated to address the consumer’s loss], but not more than four thousand dollars ($4,000); or (ii) five hundred dollars ($500); as compensation for attorney’s fees, expenses, and other costs that a consumer may incur in relation to the deceptive act.” Ind. Code § 24-5-0.5-2(a)(6). The offer must be in writing. See Ind. Code § 24-5-0.5-2(a)(5). Nexus sent its letter on October 2, 2017. It wasn’t an offer to cure. Nexus said it was “willing to work with [its] customers and would like to further investigate this matter” [ECF 128-1]. It was an offer to investigate, but not an offer to cure. The letter asked for additional information about the weight issue, despite the previous reports about the weight issue to Nexus already, but neither side offers any evidence whether additional information was provided. The letter never offered to modify or rescind the consumer transaction, never pledged to perform an offer should the Smiths accept it,

never proposed a cure that reasonably addressed the weight issue (on which the jury found for the Smiths), and never offered any compensation for fees or costs. See Ind. Code §§ 24-5-0.5-2(a)(5), (a)(6). Moreover, the letter could not operate as an offer to cure to avoid a fee or cost award because it omitted any amount of value. See Ind. Code. § 24-5-0.5-4(k). The jury’s damage award necessarily exceeded the unspoken offer, thereby preserving the right to fees and costs. See id. The court remains uncertain whether the motion on this letter seeks anything more than this. The parties argue whether the Smiths moved under Rule 50 for the court to decide this issue and whether the court can decide a motion under Rule 50 now. See Fed. R. Civ. P. 50. The record indeed shows the Smiths moved on this issue under Rule 50 [ECF 144 at 4-6, 12]. But this seems beside the point for two reasons: given that the motion for attorney fees falls under Rule 54, not Rule 50; and given the stipulation the parties reached thereafter at trial. Even so, when a court denies a motion for judgment as a matter of law at trial, the court “is considered to have submitted the action to the jury subject to the court’s later deciding the legal questions raised by the motion” under Rule 50(b). This

later motion may be made after trial. See Fed. R. Civ. P. 50(b). The parties pivoted at trial, however. Given time to discuss the issue, the parties stipulated instead to have the court decide the sufficiency of the letter as a statutory offer to cure as a matter of law [ECF 144 at 18-21]. Nexus argues there was no such stipulation—an altogether troublesome position because the trial transcript is quite clear the company did so stipulate [id.]. The parties removed from the jury the issue of whether Nexus left the deceptive act uncured—that is, whether Nexus sent an offer to cure and necessarily whether the act was cured within a reasonable time after the Smiths accepted any such offer. See Ind. Code § 24-5-0.5.-2(a)(7). The issue was otherwise covered in proposed instructions that the parties agreed to delete [ECF 113 Instrs. 6, 8].

Free access — add to your briefcase to read the full text and ask questions with AI

Smith v. Nexus RVs, LLC, (N.D. Ind. 2021).

Smith v. Nexus RVs, LLC (Smith v. Nexus RVs, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Hensley v. Eckerhart
461 U.S. 424 (Supreme Court, 1983)
Blum v. Stenson
465 U.S. 886 (Supreme Court, 1984)
City of Burlington v. Dague
505 U.S. 557 (Supreme Court, 1992)
Gisbrecht v. Barnhart
535 U.S. 789 (Supreme Court, 2002)
Sottoriva v. Claps
617 F.3d 971 (Seventh Circuit, 2010)
Fox v. Vice
131 S. Ct. 2205 (Supreme Court, 2011)
Pickett v. Sheridan Health Care Center
664 F.3d 632 (Seventh Circuit, 2011)
Kenneth Spegon v. The Catholic Bishop of Chicago
175 F.3d 544 (Seventh Circuit, 1999)
Tirapelli v. Advanced Equities, Inc.
222 F. Supp. 2d 1081 (N.D. Illinois, 2002)
Rice v. Sunrise Express, Inc.
237 F. Supp. 2d 962 (N.D. Indiana, 2002)
Hogan v. Fairfax County School Board
645 F. Supp. 2d 554 (E.D. Virginia, 2009)
Andy Montanez v. Joseph Simon
755 F.3d 547 (Seventh Circuit, 2014)
DeliverMed Holdings, LLC v. Michael Schaltenbrand
734 F.3d 616 (Seventh Circuit, 2013)
Cincinnati Life Insurance Comp v. Marjorie Beyrer
722 F.3d 939 (Seventh Circuit, 2013)
Pressley v. Haeger
977 F.2d 295 (Seventh Circuit, 1992)